SCHEMBL19081980

SCHEMBL19081980

c1cc(-c2ccc3oc4ccc5c6ccc7ccccc7c6sc5c4c3c2)cc(-c2c3ccccc3c(-c3ccc4ccccc4c3)c3ccccc23)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 5/20 0.39
CYP1B1 Q16678 4/20 0.39
CYP1A2 P05177 3/20 0.36
PLA2G2A P14555 2/20 0.34
PLA2G4A P47712 2/20 0.34
PLA2G10 O15496 1/20 0.34
HSD17B1 P14061 1/20 0.34
HSD17B2 P37059 1/20 0.34
ABCG2 Q9UNQ0 3/20 0.34
AHR P35869 2/20 0.34
PAX8 Q06710 2/20 0.34
FYN P06241 1/20 0.34
MAPK3 P27361 1/20 0.34
CASP3 P42574 1/20 0.33
SENP7 Q9BQF6 1/20 0.33
SENP6 Q9GZR1 1/20 0.33
ANO1 Q5XXA6 1/20 0.32
TDP1 Q9NUW8 2/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081964 0.94 CYP1A1 (0.36) CYP1A1CYP1B1CYP1A2PLA2G2APLA2G4A
SCHEMBL19081834 0.89 ABCG2 (0.35) CYP1A1CYP1B1CYP1A2PLA2G2APLA2G4A
SCHEMBL19081982 0.88 CYP1A1 (0.38) CYP1A1CYP1B1CYP1A2PLA2G2APLA2G4A
SCHEMBL19081876 0.87 CYP1A1 (0.40) CYP1A1CYP1B1CYP1A2ABCG2AHR
SCHEMBL17932250 0.87 PLA2G2A (0.36) CYP1A1CYP1B1CYP1A2PLA2G2APLA2G4A
SCHEMBL19081833 0.86 CYP1A1 (0.37) CYP1A1CYP1B1CYP1A2PLA2G2APLA2G4A
SCHEMBL10122670 0.86 ABCG2 (0.41) CYP1A1CYP1B1CYP1A2PLA2G2APLA2G4A
SCHEMBL10122523 0.85 ABCG2 (0.43) CYP1A1CYP1B1CYP1A2PLA2G2APLA2G4A
SCHEMBL10122547 0.85 ABCG2 (0.43) CYP1A1CYP1B1CYP1A2PLA2G2APLA2G4A
SCHEMBL10122536 0.85 ABCG2 (0.43) CYP1A1CYP1B1CYP1A2PLA2G2APLA2G4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885CYP1A2 659/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885CYP1A2 659/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.